Should alprazolam (Xanax) be used to treat anxiety in an older adult with dementia?

Alprazolam (Xanax) Should NOT Be Used to Treat Anxiety in Older Adults with Dementia

Avoid alprazolam and other benzodiazepines in older adults with dementia due to excessive risk of serious adverse events including respiratory depression, falls, delirium exacerbation, and increased mortality, without evidence of superior efficacy. 1, 2

The Evidence Against Benzodiazepines in This Population

The most recent and highest-quality evidence comes from the 2025 Geriatric Emergency Department Guidelines systematic review published in JAGS, which specifically examined medication safety in older adults with severe agitation (including those with dementia) 1. This guideline-level evidence demonstrates:

• Benzodiazepines, particularly midazolam, pose excessive risk with adverse events occurring in 53% of older adults receiving midazolam (OR 5.25 compared to haloperidol) 1
• Overall, 16.8% of older adults experienced serious adverse events when given antipsychotic or anxiolytic medications, including respiratory depression, hypotension, dysrhythmia, falls, and delirium exacerbation 1
• The guidelines explicitly state: "Benzodiazepines, particularly midazolam, pose an excessive risk to older adults" 1

FDA Label Warnings Are Explicit

The FDA label for Xanax specifically warns about risks in elderly patients 2:

• Elderly patients are especially susceptible to dose-related adverse effects
• Risks include excessive sleepiness, respiratory depression that can lead to cardiac arrest, falls, and paradoxical worsening of agitation
• Can cause delirium, confusion, and cognitive impairment
• Physical dependence develops even with prescribed use, leading to potentially life-threatening withdrawal

What the Guidelines Recommend Instead

First-Line Approach: Non-Pharmacologic Management

The 2023 dementia care guidelines emphasize that high-quality, person-centered care and psychosocial interventions are the first line for behavioral and psychological symptoms of dementia, with medication used only as a carefully monitored, short-term, last resort 3. The 2025 JAGS guidelines reinforce that nonpharmacologic approaches such as person-centered communication and sensory therapy are always preferred 1.

If Medication Is Absolutely Necessary

When nonpharmacologic approaches fail and medication becomes unavoidable 1:

1. Oral medications are preferred over parenteral - they have better safety profiles
2. Quetiapine (oral) had the best safety profile among reported medications (OR 0.27 compared to haloperidol) 1
3. Avoid benzodiazepines entirely - the American Geriatrics Society Beers Criteria recommends against benzodiazepine use in older adults independent of diagnosis 1, 4

Additional Context from Research

While older studies from the 1990s suggested alprazolam might have a role in agitated dementia patients 5, 6, these findings are superseded by:

• 2025 meta-analysis showing antidepressants (particularly SSRIs) are more effective and safer than benzodiazepines for anxiety in older adults 7
• 2023-2026 research linking benzodiazepine use to increased dementia risk in patients aged 65-75 (HR 1.28) 8, 9
• Recognition that benzodiazepines can cause paradoxical worsening of agitation in older adults 1

Critical Pitfalls to Avoid

1. Do not prescribe alprazolam for "anxiety" in dementia - what appears as anxiety is often behavioral and psychological symptoms of dementia (BPSD) requiring different management 3, 10
2. Do not assume short-term use is safe - adverse events occur even with single doses in older adults 1
3. Do not combine with other CNS depressants - the risk multiplies with concurrent antipsychotics, opioids, or other sedatives 4, 2
4. Avoid the trap of "it worked before" - tolerance develops rapidly and withdrawal can be life-threatening 2

The Clinical Algorithm

For anxiety symptoms in an older adult with dementia:

1. Identify and treat underlying causes - pain, infection, constipation, medication side effects
2. Implement nonpharmacologic interventions - environmental modification, routine optimization, caregiver education, sensory approaches
3. If severe agitation requires medication - consider oral quetiapine over benzodiazepines
4. Never use alprazolam as first-line - the risk-benefit ratio is unacceptable in this population

The evidence is clear and consistent: benzodiazepines like alprazolam should be avoided in older adults with dementia due to unacceptable safety risks without demonstrated superiority in efficacy.